WebPharmaceutical & life sciences deals outlook. We expect to see activity in areas of high expected future growth in 2024. Pharma and biotech M&A will continue to focus on oncology and immunology, but other areas such as central nervous system and cardiovascular diseases as well as vaccines will see interest. We expect that the market will place ... WebThe 8th BioCentury-BayHelix China Healthcare Summit is a propitious time to showcase how the China story promises to have a lasting impact on the global biopharma industry. …
Healthcare Systems & Services Insights McKinsey & Company
WebApr 7, 2024 · The medical device market in China is expected to expand by a 2024-2025 CAGR of 6.2%, which should see it rise to USD38.4 billion by 2025. Imports of medical devices comprised over two-thirds of China’s market, which grew by 11.1% to USD19.2 billion in 2024. U.S. suppliers captured 28.5% of China’s medical device imports in 2024, … WebDec 7, 2024 · The 19th Party Congress Fifth Plenum is completed; the 14th Five-Year Plan is in draft. Now China’s elite politics begins its run toward the quinquennial personnel changes of October 2024. In... fitbit that does not require an app
How does China’s healthcare system actually work?
WebNov 10, 2024 · On October 13, 2024 and September 26, 2024, NMPA has released two drafts for comments of the Measures for the Administration of Drug Recalls (" Draft for Comments ") respectively, and has officially adopted the 2024 Measures on October 24, 2024. The 2024 Measures is effective since November 1, 2024. http://english.nmpa.gov.cn/ WebMar 7, 2014 · October 14, 2024 – The COVID-19 pandemic has highlighted the need for resilience in vaccine manufacturing. Five considerations can help national public-health... Article August 2, 2024 – To help improve COVID-19 vaccination rates across Africa, stakeholders may consider improving research efforts to gain a better... fitbit that counts steps